FIELD: medicine, neuropathology, immunology. SUBSTANCE: method involves assay in patient with cerebrospinal sclerosis quantitative determination of CD8+ lymphocytes after incubation of patient cells with brain-specific proteins - in experiment and after incubation without brain-specific proteins - in control. An active pathological process in patient with cerebrospinal sclerosis is diagnosed if content of CD8+ lymphocytes is increased in experiment as compared with that of control typical for patient in remission state. EFFECT: increased precision of activity of pathological process. 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROGNOSIS OF FETAL THERAPY EFFECTIVENESS IN PATIENTS WITH ONCOLOGICAL SICKNESSES | 1996 |
|
RU2118819C1 |
| METHOD FOR DETERMINING PATHOLOGICAL PROCESS ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS | 2016 |
|
RU2613908C1 |
| METHOD OF PATHOLOGICAL PROCESS ACTIVITY DETERMINING IN PATIENTS WITH MULTIPLE SCLEROSIS | 2019 |
|
RU2694614C1 |
| METHOD FOR IDENTIFYING ANTIGEN/HAPTEN-SPECIFIC IMMUNOCOMPETENT BLOOD CELLS SUBPOPULATIONS | 1997 |
|
RU2128841C1 |
| METHOD OF DETECTION OF T-DEPENDENT IMMUNODEFICIENCY | 1996 |
|
RU2122209C1 |
| METHOD FOR DIAGNOSING CHRONIC PANCREATITIS CASES DEVELOPED ON THE BACKGROUND OF DUODENAL PEPTIC ULCER DISEASE | 2002 |
|
RU2249433C2 |
| METHOD FOR TREATMENT OF TROPHIC ULCER AND AGENT FOR ITS REALIZATION | 2006 |
|
RU2319507C1 |
| ANTIGEN FOR FORMING INFANT PATHOLOGY RISK GROUPS AMONG PREGNANT | 1996 |
|
RU2121685C1 |
| THERAPEUTIC AGENT FOR TREATING PATHOLOGICAL SYNDROME AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2011 |
|
RU2519196C2 |
| DRUG FOR TREATING MULTIPLE SCLEROSIS AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2010 |
|
RU2509573C2 |
